-
Valeant Pharmaceuticals International Inc. (TSX:VRX; NYSE:VRX), Montreal, Quebec Atlantis S.A. de C.V., Mexico City, Mexico Business: Generics Valeant will acquire assets from branded generic company Atlantis, including…
Published on 4/30/2012
-
Vernalis plc (LSE:VER), Winnersh, U.K. Servier, Neuilly-sur-Seine, France Business: Cancer Vernalis will receive a 500,000 ($657,550) milestone payment from Servier under a January deal to use Vernalis' fragment and …
Published on 4/30/2012
-
Zalicus Inc. (NASDAQ:ZLCS), Cambridge, Mass. Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Business: Cancer Novartis exercised its option to extend to April 2013 a 2009 deal to use combination high throughput …
Published on 4/30/2012
-
Conformetrix Ltd., Manchester, U.K. AstraZeneca plc (LSE:AZN; NYSE:AZN), London, U.K. Business: Computational chemistry/biology AstraZeneca and Conformetrix partnered to use Conformetrix's nuclear magnetic resonance (…
Published on 4/23/2012
-
Crelux GmbH, Martinsried, Germany 4SC AG (Xetra:VSC), Planegg-Martinsried, Germany Business: Supply/Service 4SC's 4SC Discovery GmbH subsidiary and Crelux partnered to provide services for drug discovery and …
Published on 4/23/2012
-
Derma Sciences Inc. (NASDAQ:DSCI), Princeton, N.J. MedEfficiency Inc., Wheat Ridge, Colo. Business: Dermatology Derma acquired MedEfficiency for $14.5 million in cash. MedEfficiency's TCC-EZ Total Contact case is a …
Published on 4/23/2012
-
DFH Pharma Inc., Gaithersburg, Md. Business: Infectious DFH and NIH's National Institute of Allergy and Infectious Diseases(NIAID) partnered to develop second generation HIV maturation inhibitor drugs. Under a material …
Published on 4/23/2012
-
Dyax Corp. (NASDAQ:DYAX), Burlington, Mass. Eclipse Therapeutics Inc., San Diego, Calif. Business: Cancer, Antibodies Dyax granted Eclipse exclusive, worldwide rights to develop and commercialize preclinical human …
Published on 4/23/2012
-
Endocyte Inc. (NASDAQ:ECYT), West Lafayette, Ind. Merck & Co. Inc. (NYSE:MRK), Whitehouse Station, N.J. Business: Cancer Endocyte grantedMerck exclusive, worldwide rights to develop and commercialize cancer compound …
Published on 4/23/2012
-
Five Prime Therapeutics Inc., South San Francisco, Calif. GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Business: Inflammation, Pulmonary GlaxoSmithKline and Five Prime partnered to identify targets and drug …
Published on 4/23/2012
-
Galapagos N.V. (Euronext:GLPG; Pink:GLPYY), Mechelen, Belgium GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Business: Infectious At its R&D day, Galapagos said it and GlaxoSmithKline mutually terminated a 2007 …
Published on 4/23/2012
-
Helicos BioSciences Corp. (Pink:HLCS), Cambridge, Mass. Sequenom Inc. (NASDAQ:SQNM), San Diego, Calif. Business: Diagnostic Sequenom acquired rights to Helicos' U.S. Patent Application Nos. 12/709,057 and 12/727,82, …
Published on 4/23/2012
-
Human Genome SciencesInc. (NASDAQ:HGSI), Rockville, Md. GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Business: Autoimmune, Cardiovascular, Endocrine/Metabolic Human Genome rejected an unsolicited takeover offer…
Published on 4/23/2012
-
Illumina Inc.(NASDAQ:ILMN), San Diego, Calif. Roche(SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Business: Microarrays, Genomics, Supply/Service Roche did not extend the April 20 deadline for its tender offer to acquire …
Published on 4/23/2012
-
Intellect Neurosciences Inc. (OTCBB:ILNS), New York, N.Y. University of California, Irvine, Calif. Business: Neurology Intellect and the university partnered to develop Intellect's RV03 to treat and prevent Alzheimer's …
Published on 4/23/2012
-
Medicago Inc. (TSX:MDG), Quebec, Quebec Business: Biomanufacturing Medicago completed a 2011 deal with an undisclosed pharma to use Medicago's transient expression system to develop a non-influenza, plant-based, virus-…
Published on 4/23/2012
-
Metabolon Inc., Durham, N.C. Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan Business: Pharmaceuticals Metabolon and Takeda partnered to discover therapeutic targets and biomarkers for an undisclosed …
Published on 4/23/2012
-
Piramal Healthcare Ltd. (BSE:50032; NSE:PIRHEALTH), Mumbai, India Bayer AG (Xetra:BAYN), Leverkusen, Germany Business: Diagnostic Piramal's Piramal Imaging S.A. subsidiary will acquire worldwide rights to the PET …
Published on 4/23/2012
-
Sanofi (Euronext:SAN; NYSE:SNY), Paris, France The Michael J. Fox Foundation for Parkinson's Research, New York, N.Y. Business: Neurology The foundation will sponsor a U.S. Phase Ib trial of Sanofi's AVE8112 in …
Published on 4/23/2012
-
Serametrix Corp., Carlsbad, Calif. Penn State Hershey Children's Hospital, Hershey, Pa. Business: Pharmacogenetics Serametrix and the university's Hershey Children's Hospital partnered to develop a serum-based …
Published on 4/23/2012
-
SomaLogic Inc., Boulder, Colo. Hunt Research Centre, Levanger, Norway Business: Diagnostic Hunt's Hunt Biosciences A/S commercial arm and SomaLogic partnered to develop protein biomarkers to predict cardiovascular …
Published on 4/23/2012
-
TapImmune Inc. (OTCBB:TPIV), Seattle, Wash. Mayo Clinic, Rochester, Minn. Business: Cancer TapImmune received exclusive, worldwide rights to major histocompatibility complex class I (MHC) EGFR 2 (HER2; ErbB2; neu) …
Published on 4/23/2012
-
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA), Rockville, Md. Eli Lilly and Co. (NYSE:LLY), Indianapolis, Ind. Business: Gastrointestinal, Neurology, Dermatology Eli Lilly granted Vanda exclusive, worldwide rights to develop…
Published on 4/23/2012
-
VistaGen Therapeutics Inc. (OTCBB:VSTA), South San Francisco, Calif. University Health Network, Toronto, Ontario Business: Gene/Cell therapy VistaGen received exclusive, worldwide rights to stem cell culture technology …
Published on 4/23/2012
-
XTL Biopharmaceuticals Ltd. (Pink:XTLBY; Tel Aviv:XTL), Valley Cottage, N.Y. Business: Pharmaceuticals XTL signed a letter of intent to acquire an undisclosed company in a stock deal plus undisclosed milestones to be …
Published on 4/23/2012